Andrew Pekosz, PhD BS
Position(s)
Co-Director, Johns Hopkins Center of Excellence in Influenza Research and Surveillance (JH-CEIRS); Director, Center for Emerging Viruses and Infectious Diseases (CEVID)
School(s)
Molecular Microbiology and Immunology, Bloomberg School of Public Health
SciVal Website Link
Current Courses Link
virus, virus assembly, virus-host interactions, respiratory infections, receptors, cell tropism, vaccines, flu, influenza, SARS-CoV, hantavirus
Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells. Fischer WA 2nd, King LS, Lane AP, Pekosz A. Vaccine. 2015 Jul 18. pii: S0264-410X(15)00967-6. doi: 10.1016/j.vaccine.2015.07.023. [Epub ahead of print]PMID:26196325
The R35 residue of the influenza A virus NS1 protein has minimal effects on nuclear localization but alters virus replication through disrupting protein dimerization. Lalime EN, Pekosz A. Virology. 2014 Jun;458-459:33-42. doi: 10.1016/j.virol.2014.04.012. Epub 2014 May 5. PMID:24928037
Sex-based biology and the rational design of influenza vaccination strategies.Klein SL, Pekosz A.J Infect Dis. 2014 Jul 15;209 Suppl 3:S114-9. doi: 10.1093/infdis/jiu066. Review.PMID:24966191
-
Stewart SM, Pekosz A. The influenza C virus CM2 protein can alter intracellular pH, and its transmembrane domain can substitute for that of the influenza A virus M2 protein and support infectious virus production. J Virol. 2012 Jan;86(2):1277-81. Epub 2011 Sep 14. PMID:21917958
Grantham ML, Stewart SM, Lalime EN, Pekosz A. Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for production of infectious virus particles. J Virol. 2010 Sep;84(17):8765-76. Epub 2010 Jun 23.PMID:20573832
- PubMED